Russell P. Hall III
J. Lamar Callaway Distinguished Professor of Dermatology, in the School of Medicine
Our laboratory is investigating the pathogenesis of autoimmune blistering skin diseases. Areas of special expertise include immune mediated skin diseases, especially immune mediated primary blistering disorders. These include pathogenesis, diagnosis, and management.
Specifically our laboratory is investigating the role of the mucosal immune response in the pathogenesis of dermatitis herpetiformis (DH) and the role the associated gluten sensitive enteropathy (GSE) plays in the development of this disease. Studies are currently focused on understanding the systemic manifestations of the mucosal immune response to dietary ingestion of wheat proteins in patients with DH. Studies are directed at determining the pattern of cytokine activation and inflammatory cell activation in the gut, skin and circulation. These studies are focused on understanding the manner in which gastrointestinal inflammation leads to the development of skin lesions in patients with DH and will provide new insight into the pathogenesis of the numerous skin diseases associated with inflammatory gastrointestinal disease.
In addition, our laboratory is investigating the pathogenesis of the organ specific auto immune blistering diseases bullous pemphigoid, and pemphigus vulgaris. These studies are directed at understanding auto-antibody epitopes and their relationship to disease activity and the role of B cells in the development and maintaince of auto-antibodies. Clinical trials are ongoing in both pemphigus and bullous pemphigoid that are coupled with mechanistic studies.
Specifically our laboratory is investigating the role of the mucosal immune response in the pathogenesis of dermatitis herpetiformis (DH) and the role the associated gluten sensitive enteropathy (GSE) plays in the development of this disease. Studies are currently focused on understanding the systemic manifestations of the mucosal immune response to dietary ingestion of wheat proteins in patients with DH. Studies are directed at determining the pattern of cytokine activation and inflammatory cell activation in the gut, skin and circulation. These studies are focused on understanding the manner in which gastrointestinal inflammation leads to the development of skin lesions in patients with DH and will provide new insight into the pathogenesis of the numerous skin diseases associated with inflammatory gastrointestinal disease.
In addition, our laboratory is investigating the pathogenesis of the organ specific auto immune blistering diseases bullous pemphigoid, and pemphigus vulgaris. These studies are directed at understanding auto-antibody epitopes and their relationship to disease activity and the role of B cells in the development and maintaince of auto-antibodies. Clinical trials are ongoing in both pemphigus and bullous pemphigoid that are coupled with mechanistic studies.
Current Appointments & Affiliations
- J. Lamar Callaway Distinguished Professor of Dermatology, in the School of Medicine, Dermatology, Clinical Science Departments 2010
- Professor of Dermatology, Dermatology, Clinical Science Departments 1996
- Professor of Immunology, Integrative Immunobiology, Basic Science Departments 1997
Contact Information
- 4044 Hosp South, Durham, NC 27710
- Duke Box 3135, Durham, NC 27710
-
hall0009@mc.duke.edu
(919) 684-0735
- Background
-
Education, Training, & Certifications
- Dermatology, Johns Hopkins University School of Medicine 1981 - 1982
- Dermatology, Clinical Center National Institutes of Health 1978 - 1981
- Dermatology, University of Missouri, Columbia School of Medicine 1977 - 1978
- Medicine, University of Missouri, Columbia School of Medicine 1976 - 1977
- Medicine, Saint Louis University 1975 - 1976
- M.D., University of Missouri - Columbia 1975
- B.A., Westminster College 1971
-
Previous Appointments & Affiliations
- Chairman, Department of Dermatology, Dermatology, Clinical Science Departments 2009 - 2021
- J. Lamar Callaway Distinguished Professor of Dermatology, in the School of Medicine, Dermatology, Clinical Science Departments 2002 - 2010
- Chief, Division of Dermatology, Dermatology, Clinical Science Departments 1998 - 2009
- Assistant Professor of Immunology, Integrative Immunobiology, Basic Science Departments 1994 - 1997
- Associate Professor of Medicine with Tenure, Dermatology, Clinical Science Departments 1990 - 1996
- Assistant Professor of Immunology, Molecular Genetics and Microbiology, Basic Science Departments 1991 - 1992
- Recognition
-
Awards & Honors
- Expertise
-
Subject Headings
- Research
-
Selected Grants
- A randomized, part A partial blinded and part B double blinded, placebo-controlled 24-week clinical study to evaluate the efficacy and safety of nomacopan therapy in adult patients with bullous pemphigoid receiving adjunct oral corticosteroid therapy awarded by Akari Therapeutics 2022 - 2024
- A Phase I, Open-Label, Multicenter Trial Exploring the Safety and Tolerability of Autologous Polyclonal Regulatory T Cell Therapy in Adults with Active Pemphigus awarded by Emory University 2019 - 2021
- An Open-Label, Proof of Concept Study Designed to Evaluate the Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients with Newly Diagnosed, Moderate to Extensive Bullous Pemphigoid awarded by Immune Pharmaceuticals 2016 - 2020
- A Phase 1b, Multicenter, Open-Label, Safety, Tolerability, and Activity Study of SYNT001 in Subjects with Chronic Pemphigus (Vulgaris or Foliaceus) awarded by Syntimmune, Inc. 2017 - 2020
- A Phase I, Open-Label, Multicenter Trial Exploring the Safety and Tolerability of Autologous Polyclonal Regulatory T Cell Therapy in Adults with Active Pemphigus awarded by University of California - San Francisco 2017 - 2019
- Training Program in Inflammatory and Immunological Diseases awarded by National Institutes of Health 1980 - 2017
- Depression & CHD: Cellular-Molecular Mechanisms awarded by National Institutes of Health 2009 - 2017
- Duke Skin Diseases Research Core Center awarded by National Institutes of Health 2014 - 2016
- CYLD Regulation of Epidermal Growth and Neoplasia awarded by National Institutes of Health 2007 - 2010
- NF-kB, CDK4 and JNK in Epidermal Growth Regulation awarded by National Institutes of Health 2005 - 2010
- Dermatitis herpetiformis and the mucosal immune response awarded by National Institutes of Health 2000 - 2006
- Dermatology Training Grant awarded by National Institutes of Health 1975 - 1998
- Dermatology Training Program awarded by National Institutes of Health 1993 - 1996
- Dermatitis Herpetiformis And The Mucosal Immune Response awarded by National Institutes of Health 1992 - 1993
- Dermatitis Herpetiformis And The Mucossal Immune Response awarded by National Institutes of Health 1989 - 1993
- Dermatitis Herpetiformis & The Mucosal Immune Response awarded by National Institutes of Health 1985 - 1988
- Dermatitis Herpetiformis And The Mucosal Immune Response awarded by National Institutes of Health 1986 - 1988
-
External Relationships
- Almiral
- Argenx
- Cowen and Company
- GLG Consultants
- Guidepost
- International Societies for Investigative Dermatology
- Quinn Emanuel Urquhart and Sullivan LLP
- Regneron
- Sanofi
- Seal Rock Therapeutics
- Society for Investigative Dermatology
- akari THerapeutics
- cabaletta Bio, Inc
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Hall, Russell P., and Kenji Kabashima. “2023 Marks the First International Societies for Investigative Dermatology Meeting in Tokyo.” J Invest Dermatol 143, no. 6 (June 2023): 886–87. https://doi.org/10.1016/j.jid.2023.02.029.Full Text Link to Item
-
Jiang, Simon W., Amy J. Petty, Jennifer L. Jacobs, Camille Robinson, Sravya M. Bhatia, Jeffery T. Kwock, Beiyu Liu, et al. “Association between age at symptom onset and disease severity in older patients with hidradenitis suppurativa.” Br J Dermatol 188, no. 4 (March 30, 2023): 555–76. https://doi.org/10.1093/bjd/ljac121.Full Text Link to Item
-
Breglio, Kimberly F., Melissa M. Sarver, Russell P. Hall, and Anne L. Marano. “SARS-CoV-2 infections in patients with autoimmune blistering disorders: A case series and retrospective analysis.” Jaad Int 7 (June 2022): 38–43. https://doi.org/10.1016/j.jdin.2022.01.003.Full Text Link to Item
-
Hall, Russell P. “Training Physician‒Scientists: A Call for a Cultural Shift in Our Approach.” Jid Innov 2, no. 1 (January 2022): 100093. https://doi.org/10.1016/j.xjidi.2021.100093.Full Text Link to Item
-
Werth, Victoria P., Donna A. Culton, Josef S. S. Concha, James S. Graydon, Laurence J. Blumberg, Joyce Okawa, Michal Pyzik, Richard S. Blumberg, and Russell P. Hall. “Safety, Tolerability, and Activity of ALXN1830 Targeting the Neonatal Fc Receptor in Chronic Pemphigus.” J Invest Dermatol 141, no. 12 (December 2021): 2858-2865.e4. https://doi.org/10.1016/j.jid.2021.04.031.Full Text Link to Item
-
Cardones, Adela R., Russell P. Hall, Keith M. Sullivan, Joanna Hooten, Seung Yun Lee, Beiyu Liu, Cynthia L. Green, et al. “Quantifying Skin Stiffness in Graft-Versus-Host Disease, Morphea, and Systemic Sclerosis Using Acoustic Radiation Force Impulse Imaging and Shear Wave Elastography.” J Invest Dermatol 141, no. 4 (April 2021): 924-927.e2. https://doi.org/10.1016/j.jid.2020.07.031.Full Text Link to Item
-
Chen, Alan, Ayumi Yoshizaki, Tomomitsu Miyagaki, Robert D. Streilein, Thomas F. Tedder, and Russell P. Hall. “Regulatory B10 Cells Increase after Rituximab Therapy but Not after Conventional Immunosuppression in Patients with Pemphigus.” J Invest Dermatol 141, no. 2 (February 2021): 443–46. https://doi.org/10.1016/j.jid.2020.06.018.Full Text Link to Item
-
Hall, Russell P. “JID Innovations: Skin Science from Molecules to Population Health.” J Invest Dermatol 140, no. 9 (September 2020): 1672–73. https://doi.org/10.1016/j.jid.2020.07.003.Full Text Link to Item
-
Murrell, Dedee F., Sandra Peña, Pascal Joly, Branka Marinovic, Takashi Hashimoto, Luis A. Diaz, Animesh A. Sinha, et al. “Diagnosis and management of pemphigus: Recommendations of an international panel of experts.” J Am Acad Dermatol 82, no. 3 (March 2020): 575-585.e1. https://doi.org/10.1016/j.jaad.2018.02.021.Full Text Link to Item
-
Bhatia, Sravya M., Robert D. Streilein, and Russell P. Hall. “Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab.” Plos One 15, no. 6 (2020): e0233957. https://doi.org/10.1371/journal.pone.0233957.Full Text Link to Item
-
Marano, A. L., A. R. Cardones, and R. P. Hall. “Inpatient Management of Autoimmune Blistering Diseases: an Update, Review, and Practical Guide.” Current Dermatology Reports 8, no. 4 (December 1, 2019): 208–18. https://doi.org/10.1007/s13671-019-00272-3.Full Text
-
Brys, Adam K., Larissa G. Rodriguez-Homs, Samantha Wennerberg, Russell P. Hall, and Matilda W. Nicholas. “Anetoderma Associated With a Succinate Dehydrogenase Gene Mutation: A Potential Link Between Anetoderma and Citric Acid Cycle Mutations.” Jama Dermatol 155, no. 11 (November 1, 2019): 1317–18. https://doi.org/10.1001/jamadermatol.2019.2579.Full Text Link to Item
-
Blanchard, S. K., K. M. Sullivan, J. N. Hooten, Z. E. Holcomb, K. Rowe Nichols, M. A. Selim, C. L. Rao, R. P. Hall, N. J. Chao, and A. R. Cardones. “High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease.” Br J Dermatol 181, no. 4 (October 2019): 869–71. https://doi.org/10.1111/bjd.18028.Full Text Link to Item
-
Marano, A. L., J. M. Clarke, M. A. Morse, A. Shah, W. Barrow, M. A. Selim, R. P. Hall, and A. R. Cardones. “Subacute cutaneous lupus erythematosus and dermatomyositis associated with anti-programmed cell death 1 therapy.” Br J Dermatol 181, no. 3 (September 2019): 580–83. https://doi.org/10.1111/bjd.17245.Full Text Link to Item
-
Zhang, Long, Wen-Hui Wang, Jane Y. Jin, Simone Degan, Guo-Qiang Zhang, Detlev Erdmann, Russell P. Hall, and Jennifer Y. Zhang. “Induction of hair follicle neogenesis with cultured mouse dermal papilla cells in de novo regenerated skin tissues.” J Tissue Eng Regen Med 13, no. 9 (September 2019): 1641–50. https://doi.org/10.1002/term.2918.Full Text Link to Item
-
Cardones, Adela R., Keith M. Sullivan, Cindy Green, Nelson J. Chao, Krista Rowe-Nichols, Lionel L. Bañez, Claude S. Burton, et al. “Interrater Reliability of Clinical Grading Measures for Cutaneous Chronic Graft-vs-Host Disease.” Jama Dermatol 155, no. 7 (July 1, 2019): 833–37. https://doi.org/10.1001/jamadermatol.2018.5459.Full Text Link to Item
-
Stanley, J. R., and R. P. Hall. “Stephen I. Katz MD PhD 1941-2019.” Br J Dermatol 180, no. 5 (May 2019): 1268–69. https://doi.org/10.1111/bjd.17787.Full Text Link to Item
-
Glass, Oliver, Ricardo Henao, Keyur Patel, Cynthia D. Guy, Hans J. Gruss, Wing-Kin Syn, Cynthia A. Moylan, et al. “Serum Interleukin-8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.” Hepatol Commun 2, no. 11 (November 2018): 1344–55. https://doi.org/10.1002/hep4.1237.Full Text Link to Item
-
Prost-Squarcioni, C., F. Caux, E. Schmidt, M. F. Jonkman, S. Vassileva, S. C. Kim, P. Iranzo, et al. “International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita.” Br J Dermatol 179, no. 1 (July 2018): 30–41. https://doi.org/10.1111/bjd.16138.Full Text Link to Item
-
Weinstock, Martin A., Robert A. Lew, Fiona M. Shaw, and Fiona M. Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial (VAKCC) Group. “Problematic End Points in a Trial of Topical Fluorouracil, 5%, for Chemoprevention of Keratinocyte Carcinoma-Reply.” Jama Dermatol 154, no. 7 (July 1, 2018): 851–52. https://doi.org/10.1001/jamadermatol.2018.1230.Full Text Link to Item
-
Lin, Lan, Bin-Jin Hwang, Donna A. Culton, Ning Li, Susan Burette, Beverly H. Koller, Kelly A. Messingham, et al. “Eosinophils Mediate Tissue Injury in the Autoimmune Skin Disease Bullous Pemphigoid.” J Invest Dermatol 138, no. 5 (May 2018): 1032–43. https://doi.org/10.1016/j.jid.2017.11.031.Full Text Link to Item
-
Carpenter, David J., Mirabelle B. Sajisevi, Nikita Chapurin, Clifford Scott Brown, Tracy Cheng, Gregory M. Palmer, Daniel S. Stevenson, Caroline L. Rao, Russell P. Hall, and Charles R. Woodard. “Noninvasive optical spectroscopy for identification of non-melanoma skin cancer: Pilot study.” Lasers Surg Med 50, no. 3 (March 2018): 246–52. https://doi.org/10.1002/lsm.22786.Full Text Link to Item
-
Lee, Jinmin, Victoria P. Werth, Russell P. Hall, Rüdiger Eming, Janet A. Fairley, David C. Fajgenbaum, Karen E. Harman, et al. “Perspective From the 5th International Pemphigus and Pemphigoid Foundation Scientific Conference.” Front Med (Lausanne) 5 (2018): 306. https://doi.org/10.3389/fmed.2018.00306.Full Text Link to Item
-
Agarwal, Ashwin, Russell P. Hall, Lionel L. Bañez, and Adela R. Cardones. “Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis.” Plos One 13, no. 9 (2018): e0198074. https://doi.org/10.1371/journal.pone.0198074.Full Text Link to Item
-
Cardones, A. R., and R. P. Hall. “Doxycycline and the treatment for bullous pemphigoid: what outcomes are most important to our patients?” Br J Dermatol 177, no. 5 (November 2017): 1145–47. https://doi.org/10.1111/bjd.15890.Full Text Link to Item
-
Labowsky, Mary T., Sandra S. Stinnett, Jason Liss, Melissa Daluvoy, Russell P. Hall, and Christine Shieh. “Clinical Implications of Direct Immunofluorescence Findings in Patients With Ocular Mucous Membrane Pemphigoid.” Am J Ophthalmol 183 (November 2017): 48–55. https://doi.org/10.1016/j.ajo.2017.08.009.Full Text Link to Item
-
Hall, Russell P. “The SID Is 80 Years Old ….and Just Getting Started.” J Invest Dermatol 137, no. 8 (August 2017): 1599–1600. https://doi.org/10.1016/j.jid.2017.06.004.Full Text Link to Item
-
Pomerantz, H., M. -. M. Chren, R. Lew, M. A. Weinstock, and M. A. VA Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial Group*. “Validation and comparison of quality-of-life measures for topical 5-fluorouracil treatment: results from a randomized controlled trial.” Clin Exp Dermatol 42, no. 5 (July 2017): 488–95. https://doi.org/10.1111/ced.13089.Full Text Link to Item
-
Chen, Yong, Carlene D. Moore, Jennifer Y. Zhang, Russell P. Hall, Amanda S. MacLeod, and Wolfgang Liedtke. “TRPV4 Moves toward Center-Fold in Rosacea Pathogenesis.” J Invest Dermatol 137, no. 4 (April 2017): 801–4. https://doi.org/10.1016/j.jid.2016.12.013.Full Text Link to Item
-
Zhang, Xiaoling, Suju Luo, Joseph Wu, Long Zhang, Wen-Hui Wang, Simone Degan, Detlev Erdmann, Russell Hall, and Jennifer Y. Zhang. “KIND1 Loss Sensitizes Keratinocytes to UV-Induced Inflammatory Response and DNA Damage.” J Invest Dermatol 137, no. 2 (February 2017): 475–83. https://doi.org/10.1016/j.jid.2016.09.023.Full Text Link to Item
-
Siegel, Julia A., Mary-Margaret Chren, Martin A. Weinstock, and Martin A. Department of Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial Group. “Correlates of skin-related quality of life (QoL) in those with multiple keratinocyte carcinomas (KCs): A cross-sectional study.” J Am Acad Dermatol 75, no. 3 (September 2016): 639–42. https://doi.org/10.1016/j.jaad.2016.05.008.Full Text Link to Item
-
Johnson, M. G., R. W. Bialas, R. P. Hall, and J. E. Stout. “Should all patients undergoing treatment with biologic agents be screened annually for latent tuberculosis infection with an interferon gamma release assay?” J Dermatolog Treat 27, no. 4 (August 2016): 378–80. https://doi.org/10.3109/09546634.2015.1115815.Full Text Link to Item
-
Cardones, Adela R., and Russell P. Hall. “Cost of Inpatient Care of Patients With Pemphigus in the United States: Translating Dollars and Cents Into Improved Patient Care.” Jama Dermatol 152, no. 6 (June 1, 2016): 629–30. https://doi.org/10.1001/jamadermatol.2015.5241.Full Text Link to Item
-
Chen, Yong, Quan Fang, Zilong Wang, Jennifer Y. Zhang, Amanda S. MacLeod, Russell P. Hall, and Wolfgang B. Liedtke. “Transient Receptor Potential Vanilloid 4 Ion Channel Functions as a Pruriceptor in Epidermal Keratinocytes to Evoke Histaminergic Itch.” J Biol Chem 291, no. 19 (May 6, 2016): 10252–62. https://doi.org/10.1074/jbc.M116.716464.Full Text Open Access Copy Link to Item
-
Liu, Xinjian, Yujun He, Fang Li, Qian Huang, Takamitsu A. Kato, Russell P. Hall, and Chuan-Yuan Li. “Redefining the roles of apoptotic factors in carcinogenesis.” Mol Cell Oncol 3, no. 3 (May 2016): e1054550. https://doi.org/10.1080/23723556.2015.1054550.Full Text Link to Item
-
Hooten, Joanna N., Russell P. Hall, Adela R. Cardones, Rui Cheng, and M Angelica Selim. “Opportunistic cutaneous fungal infections in the inpatient setting.” Int J Dermatol 55, no. 4 (April 2016): e223–26. https://doi.org/10.1111/ijd.13059.Full Text Link to Item
-
Zhang, Jennifer, Yan Wang, Jane Y. Jin, Simone Degan, Russell P. Hall, Ryan D. Boehm, Panupong Jaipan, and Roger J. Narayan. “Use of Drawing Lithography-Fabricated Polyglycolic Acid Microneedles for Transdermal Delivery of Itraconazole to a Human Basal Cell Carcinoma Model Regenerated on Mice.” Jom (1989) 68, no. 4 (April 2016): 1128–33. https://doi.org/10.1007/s11837-016-1841-1.Full Text Link to Item
-
Xiong, Glen L., Kevin Prybol, Stephen H. Boyle, Russell Hall, Robert D. Streilein, David C. Steffens, Ranga Krishnan, et al. “Inflammation Markers and Major Depressive Disorder in Patients With Chronic Heart Failure: Results From the Sertraline Against Depression and Heart Disease in Chronic Heart Failure Study.” Psychosom Med 77, no. 7 (September 2015): 808–15. https://doi.org/10.1097/PSY.0000000000000216.Full Text Link to Item
-
Zhang, X., J. Y. Jin, J. Wu, X. Qin, R. Streilein, R. P. Hall, and J. Y. Zhang. “RNA-Seq and ChIP-Seq Reveal SQSTM1/p62 as a Key Mediator of JunB Suppression of NF-κB-Dependent Inflammation.” Journal of Investigative Dermatology 135, no. 4 (April 20, 2015): 1016–24. https://doi.org/10.1038/jid.2014.519.Full Text
-
Liu, Xinjian, Yujun He, Fang Li, Qian Huang, Takamitsu A. Kato, Russell P. Hall, and Chuan-Yuan Li. “Caspase-3 promotes genetic instability and carcinogenesis.” Mol Cell 58, no. 2 (April 16, 2015): 284–96. https://doi.org/10.1016/j.molcel.2015.03.003.Full Text Link to Item
-
Cardones, A. R. G., and R. P. Hall. “Reshaping the treatment of autoimmune blistering diseases: from consensus guidelines to prospective data from 'the crowd'.” Br J Dermatol 172, no. 4 (April 2015): 845–46. https://doi.org/10.1111/bjd.13734.Full Text Link to Item
-
Zhang, Xiaoling, Jane Y. Jin, Joseph Wu, Xiaoxia Qin, Robert Streilein, Russell P. Hall, and Jennifer Y. Zhang. “RNA-Seq and ChIP-Seq reveal SQSTM1/p62 as a key mediator of JunB suppression of NF-κB-dependent inflammation.” J Invest Dermatol 135, no. 4 (April 2015): 1016–24. https://doi.org/10.1038/jid.2014.519.Full Text Open Access Copy Link to Item
-
Hall, R. P., J. Fairley, D. Woodley, V. P. Werth, D. Hannah, R. D. Streilein, J. McKillip, et al. “A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone.” Br J Dermatol 172, no. 3 (March 2015): 760–68. https://doi.org/10.1111/bjd.13350.Full Text Link to Item
-
Murrell, Dedee F., Branka Marinovic, Frederic Caux, Catherine Prost, Razzaque Ahmed, Katarzyna Wozniak, Masayuki Amagai, et al. “Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts.” J Am Acad Dermatol 72, no. 1 (January 2015): 168–74. https://doi.org/10.1016/j.jaad.2014.08.024.Full Text Link to Item
-
Liedtke, Wolfgang, Jennifer Y. Zhang, Russell P. Hall, and Martin Steinhoff. “Keratinocyte growth regulation TRP-ed up over downregulated TRPV4?” J Invest Dermatol 134, no. 9 (September 2014): 2310–12. https://doi.org/10.1038/jid.2014.250.Full Text Link to Item
-
Amagai, Masayuki, Alexander Enk, and Russell P. Hall. “The International Societies for Investigative Dermatology: the realization of a vision for unity and collaboration in the advancement of investigative dermatology and cutaneous biology.” J Invest Dermatol 134, no. 5 (May 2014): 1181–83. https://doi.org/10.1038/jid.2014.95.Full Text Link to Item
-
Ronaghy, Arash, Robert D. Streilein, and Russell P. Hall. “Rituximab decreases without preference all subclasses of IgG anti-BP180 autoantibodies in refractory bullous pemphigoid (BP).” J Dermatol Sci 74, no. 1 (April 2014): 93–94. https://doi.org/10.1016/j.jdermsci.2013.11.014.Full Text Link to Item
-
Hooten, Joanna N., Russell P. Hall, and Adela R. Cardones. “Updates on the management of autoimmune blistering diseases.” Skin Therapy Lett 19, no. 5 (2014): 1–6.Link to Item
-
Hall, Russell P., Robert D. Streilein, Deborah L. Hannah, Patrice D. McNair, Janet A. Fairley, Arash Ronaghy, Kim D. Edhegard, and Marc C. Levesque. “Association of serum B-cell activating factor level and proportion of memory and transitional B cells with clinical response after rituximab treatment of bullous pemphigoid patients.” J Invest Dermatol 133, no. 12 (December 2013): 2786–88. https://doi.org/10.1038/jid.2013.236.Full Text Link to Item
-
Gandham, V. D., R. L. Maddala, V. Rao, J. Y. Jin, D. L. Epstein, R. P. Hall, and J. Y. Zhang. “Effects of Y27632 on keratinocyte procurement and wound healing.” Clin Exp Dermatol 38, no. 7 (October 2013): 782–86. https://doi.org/10.1111/ced.12067.Full Text Link to Item
-
Lytton, Simon D., Emiliano Antiga, Sascha Pfeiffer, Torsten Matthias, Anna Szaflarska-Poplawska, Vijay K. Ulaganathan, Waldemar Placek, Paolo Fabbri, Russell Hall, and Marzia Caproni. “Neo-epitope tissue transglutaminase autoantibodies as a biomarker of the gluten sensitive skin disease--dermatitis herpetiformis.” Clin Chim Acta 415 (January 16, 2013): 346–49. https://doi.org/10.1016/j.cca.2012.10.051.Full Text Link to Item
-
Ke, H., C. K. Augustine, V. D. Gandham, J. Y. Jin, D. S. Tyler, S. K. Akiyama, R. P. Hall, and J. Y. Zhang. “CYLD inhibits melanoma growth and progression through suppression of the jnk/ap-1 and β1-integrin signaling pathways.” Journal of Investigative Dermatology 133, no. 1 (2013): 221–29. https://doi.org/10.1038/jid.2012.253.Full Text
-
Ke, Hengning, Christina K. Augustine, Vineela D. Gandham, Jane Y. Jin, Douglas S. Tyler, Steven K. Akiyama, Russell P. Hall, and Jennifer Y. Zhang. “CYLD inhibits melanoma growth and progression through suppression of the JNK/AP-1 and β1-integrin signaling pathways.” J Invest Dermatol 133, no. 1 (January 2013): 221–29. https://doi.org/10.1038/jid.2012.253.Full Text Open Access Copy Link to Item
-
DiLillo, D. J., J. B. Weinberg, A. Yoshizaki, M. Horikawa, J. M. Bryant, Y. Iwata, T. Matsushita, et al. “Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.” Leukemia 27, no. 1 (January 2013): 170–82. https://doi.org/10.1038/leu.2012.165.Full Text Link to Item
-
Dyer, Robert K., Martin A. Weinstock, Tobias S. D. Cohen, Amilcar E. Rizzo, Stephen F. Bingham, and Stephen F. VATTC Trial Group. “Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial.” J Invest Dermatol 132, no. 11 (November 2012): 2544–51. https://doi.org/10.1038/jid.2012.227.Full Text Link to Item
-
Weinstock, Martin A., Stephen F. Bingham, John J. Digiovanna, Amilcar E. Rizzo, Kim Marcolivio, Russell Hall, David Eilers, et al. “Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial.” J Invest Dermatol 132, no. 6 (June 2012): 1583–90. https://doi.org/10.1038/jid.2011.483.Full Text Link to Item
-
Cardones, Adela Rambi G., and Russell P. Hall. “Management of dermatitis herpetiformis.” Immunol Allergy Clin North Am 32, no. 2 (May 2012): 275–vii. https://doi.org/10.1016/j.iac.2012.04.007.Full Text Link to Item
-
Cardones, Adela Rambi G., and Russell P. Hall. “Pathophysiology of dermatitis herpetiformis: a model for cutaneous manifestations of gastrointestinal inflammation.” Immunol Allergy Clin North Am 32, no. 2 (May 2012): 263–vi. https://doi.org/10.1016/j.iac.2012.04.006.Full Text Link to Item
-
Murrell, Dedee F., Benjamin S. Daniel, Pascal Joly, Luca Borradori, Masayuki Amagai, Takashi Hashimoto, Frédéric Caux, et al. “Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts.” J Am Acad Dermatol 66, no. 3 (March 2012): 479–85. https://doi.org/10.1016/j.jaad.2011.06.032.Full Text Link to Item
-
Pentland, Alice P., Russell P. Hall, and Kim B. Yancey. “Happy birthday, Society for Investigative Dermatology.” J Invest Dermatol 132, no. 3 Pt 1 (March 2012): 495. https://doi.org/10.1038/jid.2011.491.Full Text Link to Item
-
Naylor, Elizabeth, Amber Atwater, M Angelica Selim, Russell Hall, and Puja K. Puri. “Leukocytoclastic vasculitis as the presenting feature of dermatitis herpetiformis.” Arch Dermatol 147, no. 11 (November 2011): 1313–16. https://doi.org/10.1001/archdermatol.2011.293.Full Text Link to Item
-
Cardones, Adela Rambi G., and Russell P. Hall. “Management of dermatitis herpetiformis.” Dermatol Clin 29, no. 4 (October 2011): 631–35. https://doi.org/10.1016/j.det.2011.06.015.Full Text Link to Item
-
Daniel, Benjamin S., Luca Borradori, Russell P. Hall, and Dédée F. Murrell. “Evidence-based management of bullous pemphigoid.” Dermatol Clin 29, no. 4 (October 2011): 613–20. https://doi.org/10.1016/j.det.2011.06.003.Full Text Link to Item
-
Cardones, Adela Rambi G., and Russell P. Hall. “Pathophysiology of dermatitis herpetiformis: a model for cutaneous manifestations of gastrointestinal inflammation.” Dermatol Clin 29, no. 3 (July 2011): 469–x. https://doi.org/10.1016/j.det.2011.03.005.Full Text Link to Item
-
Jin, Jane Y., Hengning Ke, Russell P. Hall, and Jennifer Y. Zhang. “c-Jun promotes whereas JunB inhibits epidermal neoplasia.” J Invest Dermatol 131, no. 5 (May 2011): 1149–58. https://doi.org/10.1038/jid.2011.1.Full Text Link to Item
-
Iwata, Yohei, Takashi Matsushita, Mayuka Horikawa, David J. Dilillo, Koichi Yanaba, Guglielmo M. Venturi, Paul M. Szabolcs, et al. “Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.” Blood 117, no. 2 (January 13, 2011): 530–41. https://doi.org/10.1182/blood-2010-07-294249.Full Text Link to Item
-
Ke, Hengning, Rebecca Harris, Jonathan L. Coloff, Jane Y. Jin, Benjamin Leshin, Paula Miliani de Marval, Shiying Tao, Jeffrey C. Rathmell, Russell P. Hall, and Jennifer Y. Zhang. “The c-Jun NH2-terminal kinase 2 plays a dominant role in human epidermal neoplasia.” Cancer Res 70, no. 8 (April 15, 2010): 3080–88. https://doi.org/10.1158/0008-5472.CAN-09-2923.Full Text Link to Item
-
Geng, A., M. A. Weinstock, R. Hall, D. Eilers, M. Naylor, J. Kalivas, and J. VATTC Trial Group. “Tolerability of high-dose topical tretinoin: the Veterans Affairs Topical Tretinoin Chemoprevention Trial.” Br J Dermatol 161, no. 4 (October 2009): 918–24. https://doi.org/10.1111/j.1365-2133.2009.09341.x.Full Text Link to Item
-
Rosenbach, Misha, Dedee F. Murrell, Jean-Claude Bystryn, Sam Dulay, Sarah Dick, Steve Fakharzadeh, Russell Hall, et al. “Reliability and convergent validity of two outcome instruments for pemphigus.” J Invest Dermatol 129, no. 10 (October 2009): 2404–10. https://doi.org/10.1038/jid.2009.72.Full Text Link to Item
-
Weinstock, Martin A., Stephen F. Bingham, Robert A. Lew, Russell Hall, David Eilers, Robert Kirsner, Mark Naylor, et al. “Topical tretinoin therapy and all-cause mortality.” Arch Dermatol 145, no. 1 (January 2009): 18–24. https://doi.org/10.1001/archdermatol.2008.542.Full Text Link to Item
-
Hassan, K. M., and R. P. Hall. “Bullous diseases of the skin and mucous membranes,” December 1, 2008, 935–49. https://doi.org/10.1016/B978-0-323-04404-2.10063-6.Full Text
-
Murray, John C., James A. Burch, Robert D. Streilein, Mary Ann Iannacchione, Russell P. Hall, and Sheldon R. Pinnell. “A topical antioxidant solution containing vitamins C and E stabilized by ferulic acid provides protection for human skin against damage caused by ultraviolet irradiation.” J Am Acad Dermatol 59, no. 3 (September 2008): 418–25. https://doi.org/10.1016/j.jaad.2008.05.004.Full Text Link to Item
-
Murrell, Dedee F., Sarah Dick, A. R. Ahmed, Masayuki Amagai, Maria A. Barnadas, Luca Borradori, Jean-Claude Bystryn, et al. “Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus.” J Am Acad Dermatol 58, no. 6 (June 2008): 1043–46. https://doi.org/10.1016/j.jaad.2008.01.012.Full Text Link to Item
-
Berkowitz, Paula, Luis A. Diaz, Russel P. Hall, and David S. Rubenstein. “Induction of p38MAPK and HSP27 phosphorylation in pemphigus patient skin.” J Invest Dermatol 128, no. 3 (March 2008): 738–40. https://doi.org/10.1038/sj.jid.5701080.Full Text Link to Item
-
Stryjewski, Martin E., Russell P. Hall, Vivian H. Chu, Zeina A. Kanafani, William D. O’Riordan, Michael S. Weinstock, R Scott Stienecker, et al. “Expression of antimicrobial peptides in the normal and involved skin of patients with infective cellulitis.” J Infect Dis 196, no. 9 (November 1, 2007): 1425–30. https://doi.org/10.1086/522630.Full Text Link to Item
-
Hall, Russell P., Keith M. Benbenisty, Clinzo Mickle, Fumiko Takeuchi, and Robert D. Streilein. “Serum IL-8 in patients with dermatitis herpetiformis is produced in response to dietary gluten.” J Invest Dermatol 127, no. 9 (September 2007): 2158–65. https://doi.org/10.1038/sj.jid.5700929.Full Text Link to Item
-
Hall, R. P. “Announcing "milestones in cutaneous biology".” Journal of Investigative Dermatology 127, no. 2 (February 1, 2007): 251–52. https://doi.org/10.1038/sj.jid.5700722.Full Text
-
Goldsmith, Lowell A., and Russell P. Hall. “A socratic dialogue on impact factors.” J Invest Dermatol 126, no. 9 (September 2006): 1923–24. https://doi.org/10.1038/sj.jid.5700497.Full Text Link to Item
-
Higgins, G. T., R. B. Allan, R. Hall, E. A. Field, and S. B. Kaye. “Development of ocular disease in patients with mucous membrane pemphigoid involving the oral mucosa.” Br J Ophthalmol 90, no. 8 (August 2006): 964–67. https://doi.org/10.1136/bjo.2006.092528.Full Text Link to Item
-
Goldsmith, Lowell A., Elizabeth N. Blalock, Heather Bobkova, and Russell P. Hall. “Picking your peers.” J Invest Dermatol 126, no. 7 (July 2006): 1429–30. https://doi.org/10.1038/sj.jid.5700387.Full Text Link to Item
-
Suarez, Edward C., Stephen H. Boyle, James G. Lewis, Russell P. Hall, and Kenneth H. Young. “Increases in stimulated secretion of proinflammatory cytokines by blood monocytes following arousal of negative affect: the role of insulin resistance as moderator.” Brain Behav Immun 20, no. 4 (July 2006): 331–38. https://doi.org/10.1016/j.bbi.2005.09.005.Full Text Link to Item
-
Goldsmith, Lowell A., Russell P. Hall, and Bahjat Qaqish. “Errors in the lab and in publications.” J Invest Dermatol 126, no. 6 (June 2006): 1195–96. https://doi.org/10.1038/sj.jid.5700279.Full Text Link to Item
-
Hall, Russell P., Fumiko Takeuchi, Keith M. Benbenisty, and Robert D. Streilein. “Cutaneous endothelial cell activation in normal skin of patients with dermatitis herpetiformis associated with increased serum levels of IL-8, sE-Selectin, and TNF-alpha.” J Invest Dermatol 126, no. 6 (June 2006): 1331–37. https://doi.org/10.1038/sj.jid.5700277.Full Text Link to Item
-
Myers, Sarah A., Angelica A. Selim, Margaret A. McDaniel, Russell Hall, Ying Zhang, John A. Bartlett, and Andrea L. True. “A prospective clinical and pathological examination of injection site reactions with the HIV-1 fusion inhibitor enfuvirtide.” Antivir Ther 11, no. 7 (2006): 935–39.Link to Item
-
Hall, R. P. “Perspectives: A new series of articles begins in this issue of JID.” Journal of Investigative Dermatology 125, no. 1 (January 1, 2005): 14. https://doi.org/10.1111/j.0022-202X.2005.23870.x.Full Text
-
Kong, Heidi H., Neil S. Prose, Russell E. Ware, and Russell P. Hall. “Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (rituximab).” Pediatr Dermatol 22, no. 5 (2005): 461–64. https://doi.org/10.1111/j.1525-1470.2005.00118.x.Full Text Link to Item
-
Kaplan, Andrew L., Linda H. Lee, and Russell P. Hall. “Localized facial macules and vesicles.” Arch Dermatol 140, no. 3 (March 2004): 353–58. https://doi.org/10.1001/archderm.140.3.353-g.Full Text Link to Item
-
Whited, John D., Russell P. Hall, Marjorie E. Foy, Laurie E. Marbrey, Steven C. Grambow, Tara K. Dudley, Santanu K. Datta, David L. Simel, and Eugene Z. Oddone. “Patient and clinician satisfaction with a store-and-forward teledermatology consult system.” Telemed J E Health 10, no. 4 (2004): 422–31. https://doi.org/10.1089/tmj.2004.10.422.Full Text Link to Item
-
Takeuchi, Fumiko, Robert D. Sterilein, and Russell P. Hall. “Increased E-selectin, IL-8 and IL-10 gene expression in human skin after minimal trauma.” Exp Dermatol 12, no. 6 (December 2003): 777–83. https://doi.org/10.1111/j.0906-6705.2003.00088.x.Full Text Link to Item
-
Lucas, Chere R., Linda L. Sanders, John C. Murray, Sarah A. Myers, Russell P. Hall, and James M. Grichnik. “Early melanoma detection: nonuniform dermoscopic features and growth.” J Am Acad Dermatol 48, no. 5 (May 2003): 663–71. https://doi.org/10.1067/mjd.2003.283.Full Text Link to Item
-
Whited, John D., Santanu Datta, Russell P. Hall, Marjorie E. Foy, Laurie E. Marbrey, Steven C. Grambow, Tara K. Dudley, David L. Simel, and Eugene Z. Oddone. “An economic analysis of a store and forward teledermatology consult system.” Telemed J E Health 9, no. 4 (2003): 351–60. https://doi.org/10.1089/153056203772744671.Full Text Link to Item
-
Smith, A. D., R. D. Streilein, and R. P. Hall. “Neutrophil CD11b, L-selectin and Fc IgA receptors in patients with dermatitis herpetiformis.” Br J Dermatol 147, no. 6 (December 2002): 1109–17. https://doi.org/10.1046/j.1365-2133.2002.05004.x.Full Text Link to Item
-
Szabolcs, P., M. Reese, K. B. Yancey, R. P. Hall, and J. Kurtzberg. “Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease.” Bone Marrow Transplant 30, no. 5 (September 2002): 327–29. https://doi.org/10.1038/sj.bmt.1703654.Full Text Link to Item
-
Sago, J., and R. P. Hall. “Dapsone.” Dermatologic Therapy 15, no. 4 (January 1, 2002): 340–51. https://doi.org/10.1046/j.1529-8019.2002.01543.x.Full Text
-
Whited, John D., Russell P. Hall, Marjorie E. Foy, Laurie E. Marbrey, Steven C. Grambow, Tara K. Dudley, Santanu Datta, David L. Simel, and Eugene Z. Oddone. “Teledermatology's impact on time to intervention among referrals to a dermatology consult service.” Telemed J E Health 8, no. 3 (2002): 313–21. https://doi.org/10.1089/15305620260353207.Full Text Link to Item
-
Szabolcs, P., M. Reese, K. Yancey, R. P. Hall, and K. Joanne. “Combination treatment of bullous skin gvhd with ANTI-CD20 and ANTI-CD25 antibodies.” Blood 96, no. 11 PART II (December 1, 2000).
-
Hall, R. P., A. D. Smith, and R. D. Streilein. “Increased production of IL-4 by gut T-cell lines from patients with dermatitis herpetiformis compared to patients with isolated gluten-sensitive enteropathy.” Dig Dis Sci 45, no. 10 (October 2000): 2036–43. https://doi.org/10.1023/a:1005512513007.Full Text Link to Item
-
Hall, R. P., S. Owen, A. Smith, M. Keough, B. Bagheri, P. Church, and R. Streilein. “TCR Vbeta expression in the small bowel of patients with dermatitis herpetiformis and gluten sensitive enteropathy. Limited expression in dermatitis herpetiformis and treated asymptomatic gluten sensitive enteropathy.” Exp Dermatol 9, no. 4 (August 2000): 275–82. https://doi.org/10.1034/j.1600-0625.2000.009004275.x.Full Text Link to Item
-
Roh, J. Y., C. Yee, Z. Lazarova, R. P. Hall, and K. B. Yancey. “The 120-kDa soluble ectodomain of type XVII collagen is recognized by autoantibodies in patients with pemphigoid and linear IgA dermatosis.” Br J Dermatol 143, no. 1 (July 2000): 104–11. https://doi.org/10.1046/j.1365-2133.2000.03598.x.Full Text Link to Item
-
Whited, J. D., R. P. Hall, D. L. Simel, M. E. Foy, K. M. Stechuchak, R. J. Drugge, J. M. Grichnik, S. A. Myers, and R. D. Horner. “Reliability and accuracy of dermatologists' clinic-based and digital image consultations.” J Am Acad Dermatol 41, no. 5 Pt 1 (November 1999): 693–702. https://doi.org/10.1016/s0190-9622(99)70003-4.Full Text Link to Item
-
Smith, A. D., B. Bagheri, R. D. Streilein, and R. P. Hall. “Expression of interleukin-4 and interferon-gamma in the small bowel of patients with dermatitis herpetiformis and isolated gluten-sensitive enteropathy.” Dig Dis Sci 44, no. 10 (October 1999): 2124–32. https://doi.org/10.1023/a:1026699108147.Full Text Link to Item
-
Rico, M. J., C. Benning, E. S. Weingart, R. D. Streilein, and R. P. Hall. “Characterization of skin cytokines in bullous pemphigoid and pemphigus vulgaris.” Br J Dermatol 140, no. 6 (June 1999): 1079–86. https://doi.org/10.1046/j.1365-2133.1999.02907.x.Full Text Link to Item
-
Whited, J. D., R. P. Hall, D. L. Simel, M. E. Foy, K. M. Stechuchak, R. J. Drugge, J. M. Grichnik, S. A. Myers, and R. D. Horner. “Reliability and accuracy of dermatologists' digital image consultations.” Journal of Investigative Medicine 47, no. 2 (January 1, 1999).
-
Whited, J. D., B. J. Mills, R. P. Hall, R. J. Drugge, J. M. Grichnik, and D. L. Simel. “A pilot trial of digital imaging in skin cancer.” J Telemed Telecare 4, no. 2 (1998): 108–12. https://doi.org/10.1258/1357633981932046.Full Text Link to Item
-
Whited, J. D., and R. P. Hall. “Diagnostic accuracy and precision in assessing dermatologic disease. Problem or promise?” Arch Dermatol 133, no. 11 (November 1997): 1409–15.Link to Item
-
Ishii, K., M. Amagai, R. P. Hall, T. Hashimoto, A. Takayanagi, S. Gamou, N. Shimizu, and T. Nishikawa. “Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins.” J Immunol 159, no. 4 (August 15, 1997): 2010–17.Link to Item
-
Whited, J. D., R. P. Hall, D. L. Simel, and R. D. Horner. “Primary care clinicians' performance for detecting actinic keratoses and skin cancer.” Arch Intern Med 157, no. 9 (May 12, 1997): 985–90.Link to Item
-
Rico, M. J., T. Hashimototo, K. Watanabe, R. P. Hall, R. B. Clark, and T. Nishikawa. “Comparative epitope mapping of sera from United States (US) and Japanese patients with bullous pemphigoid (BP) to fusion proteins encoded by BPAG1.” J Dermatol Sci 12, no. 3 (September 1996): 238–45. https://doi.org/10.1016/0923-1811(95)00479-3.Full Text Link to Item
-
Whited, J. D., R. D. Horner, R. P. Hall, and D. L. Simel. “Primary care clinicians' performance in the diagnosis of actinic keratoses and skin cancer.” Journal of Investigative Medicine 44, no. 1 (January 1, 1996).
-
Whited, J. D., R. D. Horner, R. P. Hall, and D. L. Simel. “The influence of history on interobserver agreement for diagnosing actinic keratoses and malignant skin lesions.” J Am Acad Dermatol 33, no. 4 (October 1995): 603–7. https://doi.org/10.1016/0190-9622(95)91278-9.Full Text Link to Item
-
Rico, M. J., R. D. Streilein, and R. P. Hall. “Peripheral blood mononuclear cells from patients with bullous pemphigoid have an increased frequency of response to synthetic peptides encoded by BPAG1.” J Invest Dermatol 103, no. 1 (July 1994): 73–77. https://doi.org/10.1111/1523-1747.ep12391682.Full Text Link to Item
-
McCord, M. L., and R. P. Hall. “IgA antibodies against reticulin and endomysium in the serum and gastrointestinal secretions of patients with dermatitis herpetiformis.” Dermatology 189 Suppl 1 (1994): 60–63. https://doi.org/10.1159/000246932.Full Text Link to Item
-
Rico, M. J., and R. P. Hall. “Cross-reactive idiotypes in the sera of patients with bullous pemphigoid express anti-basement-membrane-zone activity.” Dermatology 189 Suppl 1 (1994): 72–75. https://doi.org/10.1159/000246935.Full Text Link to Item
-
Miller, J. E., M. J. Rico, and R. P. Hall. “IgG antibodies from patients with bullous pemphigoid bind to fusion proteins encoded by BPAg1 cDNA.” J Invest Dermatol 101, no. 6 (December 1993): 779–82. https://doi.org/10.1111/1523-1747.ep12371694.Full Text Link to Item
-
Hall, R. P., J. C. Murray, M. M. McCord, M. J. Rico, and R. D. Streilein. “Rabbits immunized with a peptide encoded for by the 230-kD bullous pemphigoid antigen cDNA develop an enhanced inflammatory response to UVB irradiation: a potential animal model for bullous pemphigoid.” J Invest Dermatol 101, no. 1 (July 1993): 9–14. https://doi.org/10.1111/1523-1747.ep12358276.Full Text Link to Item
-
Rico, M. J., L. D. White, and R. P. Hall. “Expression of cross-reactive idiotypes at the basement membrane zone in patients with bullous pemphigoid.” J Invest Dermatol 100, no. 6 (June 1993): 766–70. https://doi.org/10.1111/1523-1747.ep12476347.Full Text Link to Item
-
Hall, R. P. “Dermatitis herpetiformis.” J Invest Dermatol 99, no. 6 (December 1992): 873–81. https://doi.org/10.1111/1523-1747.ep12614868.Full Text Link to Item
-
Hall, R. P., and K. D. McKenzie. “Comparison of the intestinal and serum antibody response in patients with dermatitis herpetiformis.” Clin Immunol Immunopathol 62, no. 1 Pt 1 (January 1992): 33–41. https://doi.org/10.1016/0090-1229(92)90020-o.Full Text Link to Item
-
Carpenter, S., D. Berg, N. Sidhu-Malik, R. P. Hall, and M. J. Rico. “Vancomycin-associated linear IgA dermatosis. A report of three cases.” J Am Acad Dermatol 26, no. 1 (January 1992): 45–48. https://doi.org/10.1016/0190-9622(92)70004-y.Full Text Link to Item
-
Hall, R. P., and C. Otley. “Immunogenetics of dermatitis herpetiformis.” Semin Dermatol 10, no. 3 (September 1991): 240–45.Link to Item
-
Ward, M. M., D. S. Pisetsky, and R. P. Hall. “Soluble interleukin-2 receptor levels in patients with dermatitis herpetiformis.” J Invest Dermatol 97, no. 3 (September 1991): 568–72. https://doi.org/10.1111/1523-1747.ep12481904.Full Text Link to Item
-
Otley, C. C., R. J. Wenstrup, and R. P. Hall. “DNA sequence analysis and restriction fragment length polymorphism (RFLP) typing of the HLA-DQw2 alleles associated with dermatitis herpetiformis.” J Invest Dermatol 97, no. 2 (August 1991): 318–22. https://doi.org/10.1111/1523-1747.ep12480580.Full Text Link to Item
-
Rico, M. J., L. D. White, S. Bartow, and R. P. Hall. “Detection of cross-reactive idiotypes in the serum of patients with bullous pemphigoid.” J Invest Dermatol 96, no. 6 (June 1991): 809–14. https://doi.org/10.1111/1523-1747.ep12474437.Full Text Link to Item
-
Sarret, Y., R. Hall, L. M. Cobo, J. Thivolet, D. L. Patton, and D. T. Woodley. “Salt-split human skin substrate for the immunofluorescent screening of serum from patients with cicatricial pemphigoid and a new method of immunoprecipitation with IgA antibodies.” J Am Acad Dermatol 24, no. 6 Pt 1 (June 1991): 952–58. https://doi.org/10.1016/0190-9622(91)70152-r.Full Text Link to Item
-
Hall, R. P. “Dermatitis herpetiformis and the mucosal immune response.” J Autoimmun 4, no. 1 (February 1991): 47–58. https://doi.org/10.1016/0896-8411(91)90006-x.Full Text Link to Item
-
Lightner, V. A., L. Y. Sakai, and R. P. Hall. “IgA-binding structures in dermatitis herpetiformis skin are independent of elastic-microfibrillar bundles.” J Invest Dermatol 96, no. 1 (January 1991): 88–92. https://doi.org/10.1111/1523-1747.ep12515903.Full Text Link to Item
-
Sarret, Y., R. Hall, L. M. Cobo, J. Thivolet, D. L. Patton, and D. T. Woodley. “Salt-split human skin substrate for the immunofluorescent screening of serum from patients with cicatricial pemphigoid and a new method of immunoprecipitation with IgA antibodies.” Journal of the American Academy of Dermatology 24, no. 6 I (1991): 952–58.
-
Otley, C. C., and R. P. Hall. “The pathogenesis of dermatitis herpetiformis.” Clin Dermatol 9, no. 3 (1991): 313–23. https://doi.org/10.1016/0738-081x(91)90022-d.Full Text Link to Item
-
Rico, M. J., N. J. Korman, J. R. Stanley, T. Tanaka, and R. P. Hall. “IgG antibodies from patients with bullous pemphigoid bind to localized epitopes on synthetic peptides encoded by bullous pemphigoid antigen cDNA.” J Immunol 145, no. 11 (December 1, 1990): 3728–33.Link to Item
-
Ward, M. M., R. P. Hall, and D. S. Pisetsky. “Serum interleukin-2 receptor responses to immunization.” Clin Immunol Immunopathol 57, no. 1 (October 1990): 120–24. https://doi.org/10.1016/0090-1229(90)90027-n.Full Text Link to Item
-
Otley, C., and R. P. Hall. “Dermatitis herpetiformis.” Dermatol Clin 8, no. 4 (October 1990): 759–69.Link to Item
-
Hall, R. P., F. E. Ward, and R. J. Wenstrup. “An HLA class II region restriction fragment length polymorphism (RFLP) in patients with dermatitis herpetiformis: association with HLA-DP phenotype.” J Invest Dermatol 95, no. 2 (August 1990): 172–77. https://doi.org/10.1111/1523-1747.ep12477943.Full Text Link to Item
-
Hall, R. P., R. E. Clark, and F. E. Ward. “Dermatitis herpetiformis in two American blacks: HLA type and clinical characteristics.” J Am Acad Dermatol 22, no. 3 (March 1990): 436–39. https://doi.org/10.1016/0190-9622(90)70060-u.Full Text Link to Item
-
Hall, R. P., M. E. Sanders, R. J. Duquesnoy, S. I. Katz, and S. Shaw. “Alterations in HLA-DP and HLA-DQ antigen frequency in patients with dermatitis herpetiformis.” J Invest Dermatol 93, no. 4 (October 1989): 501–5. https://doi.org/10.1111/1523-1747.ep12284056.Full Text Link to Item
-
Singer, K. H., D. T. Tuck, H. A. Sampson, and R. P. Hall. “Epidermal keratinocytes express the adhesion molecule intercellular adhesion molecule-1 in inflammatory dermatoses.” J Invest Dermatol 92, no. 5 (May 1989): 746–50. https://doi.org/10.1111/1523-1747.ep12722441.Full Text Link to Item
-
Rico, M. J., and R. P. Hall. “Anti-idiotypic antibodies as vaccine candidates. The immune network.” Arch Dermatol 125, no. 2 (February 1989): 271–75.Link to Item
-
Hall, R. P., M. F. Hundley, and A. Zettl. “Switching and charge-density-wave transport in NbSe3. I. dc characteristics.” Phys Rev B Condens Matter 38, no. 18 (December 15, 1988): 13002–18. https://doi.org/10.1103/physrevb.38.13002.Full Text Link to Item
-
Hall, R. P., and A. Zettl. “Switching and charge-density-wave transport in NbSe3. II. ac characteristics.” Phys Rev B Condens Matter 38, no. 18 (December 15, 1988): 13019–27. https://doi.org/10.1103/physrevb.38.13019.Full Text Link to Item
-
Inui, M., R. P. Hall, S. Doniach, and A. Zettl. “Phase slips and switching in charge-density-wave transport.” Phys Rev B Condens Matter 38, no. 18 (December 15, 1988): 13047–60. https://doi.org/10.1103/physrevb.38.13047.Full Text Link to Item
-
Sherwin, M. S., A. Zettl, and R. P. Hall. “Switching and charge-density-wave transport in NbSe3. III. Dynamical instabilities.” Phys Rev B Condens Matter 38, no. 18 (December 15, 1988): 13028–46. https://doi.org/10.1103/physrevb.38.13028.Full Text Link to Item
-
Rico, M. J., and R. P. Hall. “Idiotypes, anti-idiotypes, and autoimmunity.” J Am Acad Dermatol 19, no. 3 (September 1988): 579–85. https://doi.org/10.1016/s0190-9622(88)70212-1.Full Text Link to Item
-
Hall, R. P., and G. V. Waldbauer. “Characterization of the mucosal immune response to dietary antigens in patients with dermatitis herpetiformis.” J Invest Dermatol 90, no. 5 (May 1988): 658–63. https://doi.org/10.1111/1523-1747.ep12560821.Full Text Link to Item
-
Hall, R. P. “Dietary management of dermatitis herpetiformis.” Arch Dermatol 123, no. 10 (October 1987): 1378a-1380a.Link to Item
-
Hall, R. P., and R. W. Eyre. “IgA immune complexes in patients with dermatitis herpetiformis occur in the absence of IgA rheumatoid factor.” J Invest Dermatol 89, no. 1 (July 1987): 27–31. https://doi.org/10.1111/1523-1747.ep12580310.Full Text Link to Item
-
Hall, R. P. “The pathogenesis of dermatitis herpetiformis: recent advances.” J Am Acad Dermatol 16, no. 6 (June 1987): 1129–44. https://doi.org/10.1016/s0190-9622(87)70148-0.Full Text Link to Item
-
Hall, R. P., M. F. Hundley, and A. Zettl. “Switching and phase-slip centers in charge-density-wave conductors.” Phys Rev Lett 56, no. 22 (June 2, 1986): 2399–2402. https://doi.org/10.1103/PhysRevLett.56.2399.Full Text Link to Item
-
Sherwin, M. S., R. P. Hall, and A. Zettl. “Sherwin, Hall, and Zettl respond.” Phys Rev Lett 55, no. 27 (December 30, 1985): 3008. https://doi.org/10.1103/PhysRevLett.55.3008.Full Text Link to Item
-
Hall, R. P., and T. J. Lawley. “Characterization of circulating and cutaneous IgA immune complexes in patients with dermatitis herpetiformis.” J Immunol 135, no. 3 (September 1985): 1760–65.Link to Item
-
Hall, R. P., W. M. Leiserson, T. M. Chused, and T. J. Lawley. “Characterization of T lymphocyte and monocyte populations in HLA B8/DRw3 normal individuals and in patients with dermatitis herpetiformis.” J Invest Dermatol 82, no. 3 (March 1984): 231–34. https://doi.org/10.1111/1523-1747.ep12260103.Full Text Link to Item
-
Yancey, K. B., R. P. Hall, and T. J. Lawley. “Pruritic urticarial papules and plaques of pregnancy. Clinical experience in twenty-five patients.” J Am Acad Dermatol 10, no. 3 (March 1984): 473–80. https://doi.org/10.1016/s0190-9622(84)80097-3.Full Text Link to Item
-
Hall, R. P., L. H. Gerber, and T. J. Lawley. “IgA-containing immune complexes in patients with psoriatic arthritis.” Clin Exp Rheumatol 2, no. 3 (1984): 221–25.Link to Item
-
Fields, T. R., E. N. Gerardi, B. Ghebrehiwet, R. S. Bennett, T. J. Lawley, R. P. Hall, P. H. Plotz, J. R. Karsh, M. M. Frank, and M. I. Hamburger. “Reticuloendothelial system fc receptor function in rheumatoid arthritis.” J Rheumatol 10, no. 4 (August 1983): 550–57.Link to Item
-
Hall, R. P., G. L. Peck, and T. J. Lawley. “Circulating IgA immune complexes in patients with psoriasis.” J Invest Dermatol 80, no. 6 (June 1983): 465–68. https://doi.org/10.1111/1523-1747.ep12534883.Full Text Link to Item
-
Yancey, K. B., J. C. Cason, R. P. Hall, and T. J. Lawley. “Dietary gluten challenge does not influence the levels of circulating immune complexes in patients with dermatitis herpetiformis.” J Invest Dermatol 80, no. 6 (June 1983): 468–71. https://doi.org/10.1111/1523-1747.ep12534895.Full Text Link to Item
-
Hall, R. P. “Methods for the detection of circulating immune complexes.” Plasma Therapy and Transfusion Technology 4, no. 2 (January 1, 1983): 111–18.
-
Wei, N., J. H. Klippel, D. P. Huston, R. P. Hall, T. J. Lawley, J. E. Balow, A. D. Steinberg, and J. L. Decker. “Randomised trial of plasma exchange in mild systemic lupus erythematosus.” Lancet 1, no. 8314–5 (January 1, 1983): 17–22. https://doi.org/10.1016/s0140-6736(83)91561-1.Full Text Link to Item
-
Hall, R. P., I. Stachura, J. Cason, T. L. Whiteside, and T. J. Lawley. “IgA-containing circulating immune complexes in patients with igA nephropathy.” Am J Med 74, no. 1 (January 1983): 56–63. https://doi.org/10.1016/0002-9343(83)91118-x.Full Text Link to Item
-
Hall, R. P., T. J. Lawley, and S. I. Katz. “Bullous eruption of systemic lupus erythematosus.” J Am Acad Dermatol 7, no. 6 (December 1982): 797–99. https://doi.org/10.1016/s0190-9622(82)80159-x.Full Text Link to Item
-
Fries, L. F., R. P. Hall, T. J. Lawley, G. R. Crabtree, and M. M. Frank. “Monocyte receptors for the Fc portion of IgG studies with monomeric human IgG1: normal in vitro expression of Fc gamma receptors in HLA-B8/Drw3 subjects with defective Fc gamma-mediated in vivo clearance.” J Immunol 129, no. 3 (September 1982): 1041–49.Link to Item
-
Chesney, A. P., J. A. Chavira, R. P. Hall, and H. E. Gary. “Barriers to medical care of Mexican-Americans: the role of social class, acculturation, and social isolation.” Med Care 20, no. 9 (September 1982): 883–91. https://doi.org/10.1097/00005650-198209000-00002.Full Text Link to Item
-
Hall, R. P., T. J. Lawley, H. R. Smith, and S. I. Katz. “Bullous eruption of systemic lupus erythematosus. Dramatic response to dapsone therapy.” Ann Intern Med 97, no. 2 (August 1982): 165–70. https://doi.org/10.7326/0003-4819-97-2-165.Full Text Link to Item
-
Gentry, W. D., A. P. Chesney, H. E. Gary, R. P. Hall, and E. Harburg. “Habitual anger-coping styles: I. Effect on mean blood pressure and risk for essential hypertension.” Psychosom Med 44, no. 2 (May 1982): 195–202. https://doi.org/10.1097/00006842-198205000-00005.Full Text Link to Item
-
Rose, R. M., C. D. Jenkins, M. Hurst, B. E. Kreger, J. Barrett, and R. P. Hall. “Endocrine activity in air traffic controllers at work. III. Relationship to physical and psychiatric morbidity.” Psychoneuroendocrinology 7, no. 2–3 (1982): 125–34. https://doi.org/10.1016/0306-4530(82)90004-x.Full Text Link to Item
-
Rose, R. M., C. D. Jenkins, M. Hurst, J. A. Herd, and R. P. Hall. “Endocrine activity in air traffic controllers at work. II. Biological, psychological and work correlates.” Psychoneuroendocrinology 7, no. 2–3 (1982): 113–23. https://doi.org/10.1016/0306-4530(82)90003-8.Full Text Link to Item
-
Rose, R. M., C. D. Jenkins, M. Hurst, L. Livingston, and R. P. Hall. “Endocrine activity in air traffic controllers at work. I. Characterization of cortisol and growth hormone levels during the day.” Psychoneuroendocrinology 7, no. 2–3 (1982): 101–11. https://doi.org/10.1016/0306-4530(82)90002-6.Full Text Link to Item
-
Sauder, D. N., R. P. Hall, and C. F. Wurster. “Dermal myiasis: the porcine lipid cure.” Arch Dermatol 117, no. 11 (November 1981): 681–82. https://doi.org/10.1001/archderm.1981.01650110003001.Full Text Link to Item
-
Eisler, T., R. P. Hall, K. A. Kalavar, and D. B. Calne. “Erythromelalgia-like eruption in parkinsonian patients treated with bromocriptine.” Neurology 31, no. 10 (October 1981): 1368–70. https://doi.org/10.1212/wnl.31.10.1368.Full Text Link to Item
-
Hall, R. P., W. Strober, S. I. Katz, and T. J. Lawley. “IgA-containing circulating immune complexes in gluten-sensitive enteropathy.” Clin Exp Immunol 45, no. 2 (August 1981): 234–39.Link to Item
-
Hall, R. P., T. J. Lawley, and S. I. Katz. “Dermatitis herpetiformis.” Springer Semin Immunopathol 4, no. 1 (June 1981): 33–43. https://doi.org/10.1007/BF01891883.Full Text Link to Item
-
Foidart, J. M., M. Yaar, R. Hall, U. Gaspard, and S. I. Katz. “Immunopathological and clinical studies in herpes gestationis.” Br J Obstet Gynaecol 88, no. 2 (February 1981): 153–59. https://doi.org/10.1111/j.1471-0528.1981.tb00961.x.Full Text Link to Item
-
Lawley, T. J., R. P. Hall, A. S. Fauci, S. I. Katz, M. I. Hamburger, and M. M. Frank. “Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects.” N Engl J Med 304, no. 4 (January 22, 1981): 185–92. https://doi.org/10.1056/NEJM198101223040401.Full Text Link to Item
-
Gentry, W. D., J. D. Oude-Weme, F. Musch, and R. P. Hall. “Differences in types A and B behavior in response to acute myocardial infarction.” Heart Lung 10, no. 6 (1981): 1101–5.Link to Item
-
Lawley, T. J., and R. P. Hall. “Circulating immune complexes in dermatologic disease.” Springer Semin Immunopathol 4, no. 3 (1981): 221–40. https://doi.org/10.1007/BF01892179.Full Text Link to Item
-
Katz, S. I., R. P. Hall, T. J. Lawley, and W. Strober. “Dermatitis herpetiformis: the skin and the gut.” Ann Intern Med 93, no. 6 (December 1980): 857–74. https://doi.org/10.7326/0003-4819-93-6-857.Full Text Link to Item
-
Hall, R. P., T. J. Lawley, J. A. Heck, and S. I. Katz. “IgA-containing circulating immune complexes in dermatitis herpetiformis, Henoch-Schönlein purpura, systemic lupus erythematosus and other diseases.” Clin Exp Immunol 40, no. 3 (June 1980): 431–37.Link to Item
-
Eisler, T., R. P. Hall, K. A. R. Kalavar, and D. B. Calne. “Erythromelalgia-like eruption in parkinsonian patients treated with bromocriptine.” Neurology 29, no. 4 (January 1, 1979): 571.
-
Cuddihy, T. G., R. P. Hall, and W. C. Griffith. “Inhalation exposures to barium aerosols: physical, chemical and mathematical analysis.” Health Phys 26, no. 5 (May 1974): 405–16. https://doi.org/10.1097/00004032-197405000-00004.Full Text Link to Item
-
-
Book Sections
-
Bhatia, S. M., and R. P. Hall. “Dapsone.” In Comprehensive Dermatologic Drug Therapy, Fourth Edition, 222-233.e4, 2020. https://doi.org/10.1016/B978-0-323-61211-1.00020-6.Full Text
-
Nicholas, Matilda, Russell Hall, and caroline Rao. “Chapter 61: Linear Immunoglobulin A Dermatosis and Chronic Bullous Disease of Childhood.” In Fitzpatrick’s Dermatology, 2019.
-
Cardones, A. R. G., and R. P. Hall. “Bullous Diseases of the Skin and Mucous Membranes.” In Clinical Immunology: Principles and Practice, 857-870.e1, 2019. https://doi.org/10.1016/B978-0-7020-6896-6.00063-6.Full Text
-
Borradori, L., D. F. Murrell, and R. P. Hall. “Bullous Pemphigoid (Cutaneous Pemphigoid): The Spectrum of Clinical Presentations.” In Blistering Diseases: Clinical Features, Pathogenesis, Treatment, 335–42, 2015. https://doi.org/10.1007/978-3-662-45698-9_31.Full Text
-
George, R., A. R. G. Cardones, D. F. Murrell, and R. P. Hall. “Treatment of Dermatitis Herpetiformis.” In Blistering Diseases: Clinical Features, Pathogenesis, Treatment, 573–78, 2015. https://doi.org/10.1007/978-3-662-45698-9_60.Full Text
-
Ramirez-Quizon, M. N., L. Borradori, R. P. Hall, and D. F. Murrell. “Management of Bullous Pemphigoid.” In Blistering Diseases: Clinical Features, Pathogenesis, Treatment, 543–50, 2015. https://doi.org/10.1007/978-3-662-45698-9_55.Full Text
-
Edhegard, K. D., and R. P. Hall. “Bullous diseases of the skin and mucous membranes.” In Clinical Immunology: Principles and Practice: Fourth Edition, 760–74, 2013. https://doi.org/10.1016/B978-0-7234-3691-1.00076-3.Full Text
-
Edhegard, K., and R. P. Hall. “Dapsone.” In Comprehensive Dermatologic Drug Therapy: Expert Consult - Online and Print, 228–40, 2012. https://doi.org/10.1016/B978-1-4377-2003-7.00018-2.Full Text
-
Hassan, K. M., and R. P. Hall. “Bullous diseases of the skin and mucous membranes: Pemphigus Vulgaris.” In Clinical Immunology: Principles and Practice Expert Consult: Online and Print, 935–49, 2008. https://doi.org/10.1016/B978-0-323-04404-2.10063-6.Full Text
-
-
Conference Papers
-
Pomerantz, Hyemin, Daniel Hogan, David Eilers, Susan M. Swetter, Suephy C. Chen, Sharon E. Jacob, Erin M. Warshaw, et al. “Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.” In Jama Dermatol, 151:952–60, 2015. https://doi.org/10.1001/jamadermatol.2015.0502.Full Text Link to Item
-
-
Datasets
-
Cardones, Adela, Nicole Leung, Keith Sullivan, Nelson Chao, Cynthia Green, Lionel Bañez, Mark L. Palmeri, et al. “Data from: Quantifying skin stiffness in graft-versus-host disease, morphea and systemic sclerosis using acoustic radiation force impulse imaging and shear wave elastography,” July 2, 2020. https://doi.org/10.7924/r4h995b4q.Data Access
-
Hall, Russell, R. D. Streilein, and Sravya M. Bhatia. “Data from: Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab,” June 2, 2020. https://doi.org/10.7924/r4rf5r157.Data Access
-
Cardones, Adela, A. Agarwal, R. Hall, and L. Bañez. “Data from: Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis,” June 5, 2018. https://doi.org/10.7924/r4vh5gw86.Data Access
-
-
- Scholarly, Clinical, & Service Activities
-
Service to the Profession
- President. Society for Investigative Dermatology. 2017 2017
- President-Elect. Society for Investigative Dermatology. 2016 - 2017 2016 - 2017
- Secretary-Treasurer. Society for Investigative Dermatology. 2011 - 2014 2011 - 2014
- Assistant Secretary-Treasurer. Society for Investigative Dermatology. 2008 - 2011 2008 - 2011
- Nominating Committee. Society for Investigative Dermatology. 2007 - 2010 2007 - 2010
- Secretary-Treasurer. Medical Dermatology Society. 2007 - 2010 2007 - 2010
- Membership Committee. American Dermatological Association. 2004 - 2009 2004 - 2009
- Board of Directors. Association of Professors of Dermatology. 2003 - 2006 2003 - 2006
- Deputy Editor. Journal of Investigative Dermatology. 2002 - 2008 2002 - 2008
- Board of Directors. Society for Investigative Dermatology. 1996 - 2001 1996 - 2001
- Membership Committee. Society for Investigative Dermatology. 1993 - 1996 1993 - 1996
- Deputy Editor. Journal of Investigative Dermatology. 1992 - 1997 1992 - 1997
- President. National Association of Veterans Affairs Dermatologists. 1991 - 1992 1991 - 1992
- Board of Directors. Society for Investigative Dermatology. 1980 - 1982 1980 - 1982
- Resident-Fellow Committee. Society for Investigative Dermatology. 1980 - 1982 1980 - 1982
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.